Monkeypox history and symptoms: Difference between revisions
Jump to navigation
Jump to search
Jose Loyola (talk | contribs) No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
Interim clinical, laboratory and epidemiologic criteria for case classification — U.S. Monkeypox Response, May 2022 | |||
{| class="wikitable" | |||
|Clinical and laboratory classification | |||
|Criteria | |||
|- | |||
|Suspected | |||
|New characteristic rash* OR | |||
|- | |||
| | |||
|Meets one of the epidemiologic criteria and has high clinical suspicion† for monkeypox | |||
|- | |||
|Probable | |||
|No suspicion of other recent orthopoxvirus exposure (e.g., Vaccinia virus in ACAM2000 vaccination) AND demonstration of the presence of | |||
|- | |||
| | |||
|• Orthopoxvirus DNA by polymerase chain reaction testing of a clinical specimen OR | |||
|- | |||
| | |||
|• Orthopoxvirus using immunohistochemical or electron microscopy testing methods | |||
start highlight | |||
OR | |||
end highlight | |||
|- | |||
| | |||
|start highlight | |||
• Detectable levels of antiorthopoxvirus IgM antibody during the period of 4–56 days after rash onset | |||
end highlight | |||
|- | |||
|Confirmed | |||
|Demonstration of the presence of Monkeypox virus DNA by polymerase chain reaction testing or next-generation sequencing of a clinical specimen OR | |||
|- | |||
| | |||
|Isolation of Monkeypox virus in culture from a clinical specimen | |||
|- | |||
|Epidemiologic classification | |||
| | |||
|} | |||
__NOTOC__ | __NOTOC__ | ||
{{Monkeypox}} | {{Monkeypox}} | ||
Revision as of 20:26, 14 June 2022
Interim clinical, laboratory and epidemiologic criteria for case classification — U.S. Monkeypox Response, May 2022
| Clinical and laboratory classification | Criteria |
| Suspected | New characteristic rash* OR |
| Meets one of the epidemiologic criteria and has high clinical suspicion† for monkeypox | |
| Probable | No suspicion of other recent orthopoxvirus exposure (e.g., Vaccinia virus in ACAM2000 vaccination) AND demonstration of the presence of |
| • Orthopoxvirus DNA by polymerase chain reaction testing of a clinical specimen OR | |
| • Orthopoxvirus using immunohistochemical or electron microscopy testing methods
start highlight OR end highlight | |
| start highlight
• Detectable levels of antiorthopoxvirus IgM antibody during the period of 4–56 days after rash onset end highlight | |
| Confirmed | Demonstration of the presence of Monkeypox virus DNA by polymerase chain reaction testing or next-generation sequencing of a clinical specimen OR |
| Isolation of Monkeypox virus in culture from a clinical specimen | |
| Epidemiologic classification |
|
Monkeypox Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Monkeypox history and symptoms On the Web |
|
American Roentgen Ray Society Images of Monkeypox history and symptoms |
|
Risk calculators and risk factors for Monkeypox history and symptoms |